Michael K Turgeon

4PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 11, 2021
Do Oncologic Outcomes From Head and Neck Versus Truncal and Extremity Melanoma Differ? A Single-Institution Single-Subspecialty Experience.

Kirsten M Baecher, Michael K Turgeon, Caroline R Medin

|Aug 11, 2021
Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysis.

Joshua P Kronenfeld, Amber L Collier, Michael K Turgeon

|Jul 16, 2021
Radiological assessment of persistent retroperitoneal and lateral pelvic lymph nodes after neoadjuvant therapy for rectal cancer: An analysis of the United States Rectal Cancer Consortium.

Michael K Turgeon, Adriana C Gamboa, Jessica M Keilson

|Jun 01, 2021
Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?

Michael K Turgeon, Rachel M Lee, Jessica M Keilson

Pageof 1

Frequent Collaborators

2 joint publications

Matthew R Porembka

2 joint publications

Joshua P Kronenfeld

2 joint publications

Maria C Russell

1 joint publications

Rachel M Lee